The study was a multi-center, controlled trial examining the safety and efficacy of the Superion ISS compared to the X-Stop IPD. The system is designed to perform a minimally invasive surgical technique.
Related Articles on Spine Surgery:
Minimally Invasive TLIF Has Economic Benefits Over Open Surgery
Study Analyzes Impact of Growing Rod Lengthening Surgery Overtime
Now is a Great Time to be a Physician: Q&A With Dr. John Caruso on Physician Involvement in Healthcare Changes
VertiFlex Completes Superion Interspinous Trial Enrollment
VertiFlex, a San Clemente, Calif.-based spine device company, has completed enrollment for its IDE clinical trail for the Superion Interspinous Spacer, according to a company news release.
From manual to manageable: How AI and partnerships are transforming urology RCM
Recommended Whitepaper